Across TCGA pan-cancer cohorts, TRAV7 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated TRAV7 data layer compared with 3 for mutation status.
The strongest signal is observed in thyroid carcinoma (THCA), where higher TRAV7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TRAV7 expression acts as an unfavorable survival marker, although some lineages such as MESO show a favorable association.
THCA, LGG, and GBM are the cancer types where TRAV7 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.